M-033

N/A

Report date: 2025/03/18 13:50:26

Base Information

Drug NameM-033
Drug Alias NameM-033Lenti-GALC-S1S3
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGalactocerebrosidase replacementsGene transference
TargetsGalactocerebrosidase
Therapy Area/IndicationsLeukodystrophy, Globoid Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesM6P Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesM6P Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsLeukodystrophy, Globoid Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A